ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic Polymorphism and Israeli Top-level Athletes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01319071
Recruitment Status : Unknown
Verified March 2011 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : March 21, 2011
Last Update Posted : March 21, 2011
Sponsor:
Collaborator:
Wingate Institute
Information provided by:
Hillel Yaffe Medical Center

Brief Summary:
It is still unknown whether different genetic elements play a role in athletes' ability to create their area of specificity.In a study conducted in our laboratory few years ago, we genotyped 22 genes in 2 athletic groups (endurance and sprinters) and in age and gender matched nonathletic controls. Few of these genes were found to be associated with athletic performance and area of specificity. Since then a few more genes have been found that are related to athletic performance, and our aim in the current study is to expand our research to these new genes which include 3 genetic cascades: genes associated with body fluid balance and homeostasis, genes associated with muscle strength, and genes associated with bioenergy.

Condition or disease Intervention/treatment
Top-level Athletes Other: Blood sample

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : April 2011
Estimated Primary Completion Date : December 2011
Estimated Study Completion Date : December 2012

Group/Cohort Intervention/treatment
Top-level athletes Other: Blood sample
Extraction of blood sample from top-level athletes

Control group Other: Blood sample
Extraction of blood sample from top-level athletes




Primary Outcome Measures :
  1. Identification of genes related to top-level athletes [ Time Frame: Four months ]

Biospecimen Retention:   Samples With DNA
Whole blood


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 40 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Athletes training at the Wingate Institute
Criteria

Inclusion Criteria:

  • Top-level athletes
  • Other athletes

Exclusion Criteria:

  • All others

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01319071


Locations
Israel
Wingate Institute Not yet recruiting
Netanya, Israel
Contact: Sigal Ben Zaken, PhD    972-52-2209853      
Principal Investigator: Sigal Ben Zaken, PhD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
Wingate Institute

Responsible Party: Eias Kassem, MD, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01319071     History of Changes
Other Study ID Numbers: 0015-11-HYMC
First Posted: March 21, 2011    Key Record Dates
Last Update Posted: March 21, 2011
Last Verified: March 2011